Veronique Michaud, B.Pharm., Ph.D. is the Chief Operating Officer of TRHC’s Scientific Precision Pharmacotherapy Research & Development Institute in Orlando. The institute aims at developing advanced clinical decision support systems to optimize medication safety.
Dr. Michaud is an adjunct professor, Faculty of pharmacy, Université de Montréal and has directed a pharmacokinetic and bioanalytic core facility at the CRCHUM. Her research investigates the contribution of CYP450 drug-metabolizing enzymes in drug disposition, with special attention to the role of disease states (focusing on type 2 diabetes), the role of pharmacogenomics, and drug-drug interactions while attempting to better understand and predict variation in drug responses. She has earned more than $22 million in research awards, published more than 51 peer-reviewed journal articles and mentored graduate students and PharmD residents. Dr. Michaud completed fellowships at Indiana University and McGill University and earned her Ph.D. and M.Sc. degrees from the Université de Montréal.